LLY compared with AMRX: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

AMRXAmneal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

AMRXAmneal Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

AMRX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 3 '26thin chain±22.7%▼−1.13%×0.05

Q2 FY26±15.6%▼−3.14%×0.20

= impliedLLY realized, solidAMRX realized, hatchedOne scale, both sides: full bar = 23%× = |realized| ÷ impliedSource: market data

May 8 '26±10.1%▼−3.79%×0.38

Q1 FY26±21.3%▼−1.54%×0.07

LLYELI Lilly & Co

1,371.32· pre 1,350.01· delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

AMRXAmneal Pharmaceuticals, Inc.

19.45· pre 19.34· delayed

Pre-marketNov 6 '26delayed

Mkt cap$6.4BRevenue$796MQ2 FY26Revenue$3.0BFY25

Compare

Pre-marketNov 6 '26delayed

LLYELI Lilly & Co

AMRXAmneal Pharmaceuticals, Inc.

1,371.32pre 1,350.01delayed

Price

19.45pre 19.34delayed

$1.2T

Mkt cap

$6.4B

Q3 FY26$24.4B

Revenue

$796MQ2 FY26

FY25$65.2B

Revenue

$3.0BFY25

LLY1,371.32vsAMRX19.45Pre-marketNov 6 '26delayed